Zim Laboratories Share Price
Zim Laboratories Share Price Today
As of 5 Jul 2026, Zim Laboratories share price is ₹122.01. The stock opened at ₹122.01, compared to its previous close of ₹124.50. During today's trading session, Zim Laboratories share price moved in the range of ₹122.01 to ₹124.50, with an average price of ₹123.25 for the day. Looking at its last 52-week, the stock has touched a low of ₹59.31 and a high of ₹133.90. On the performance front, Zim Laboratories share price has increased by 73.24% over the last six months and is up 13.15% on a year-on-year basis.
Zim Laboratories Returns Calculator
Zim Laboratories Shareholder Returns
Zim Laboratories Share Price History
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 4,49,048.00 | 39.02 | 5.37 | 13.74% | 0.61 | 17.33% | 93.24 | 0.85% | 0.56 | 10.90 |
| Divis Laboratories | 1,77,179.00 | 69.00 | 10.57 | 15.32% | 0.00 | 19.56% | 629.49 | 0.45% | 0.58 | 98.19 |
| Torrent Pharmaceuticals | 1,57,804.00 | 66.03 | 17.03 | 26.76% | 1.05 | 18.30% | 16.90 | 0.90% | 0.49 | 64.75 |
| Cipla | 1,17,642.00 | 25.47 | 2.87 | 11.79% | 0.00 | 15.66% | 2.89 | 1.06% | 0.49 | 43.52 |
| Dr. Reddy's Laboratories | 1,12,368.00 | 27.03 | 2.97 | 11.07% | 0.18 | 12.54% | 375.78 | 0.59% | 0.63 | 38.68 |
| Zydus Lifesciences | 1,10,651.00 | 21.60 | 4.08 | 18.59% | 0.31 | 17.35% | 235.25 | 0.09% | 0.39 | 35.38 |
| Lupin | 1,09,676.00 | 20.48 | 4.89 | 23.76% | 0.04 | 24.88% | 659.05 | 0.75% | 0.61 | 129.18 |
| Mankind Pharma | 1,02,729.00 | 53.00 | 6.30 | 11.74% | 0.34 | 13.13% | 397.02 | 0.04% | 0.54 | 49.37 |
| Aurobindo Pharma | 90,608.00 | 25.87 | 2.39 | 9.25% | 0.19 | 11.76% | 391.14 | 0.26% | 0.48 | 41.58 |
| Laurus Labs | 82,398.90 | 60.26 | 10.10 | 18.21% | 0.45 | 16.70% | 10.19 | 0.20% | 0.97 | 13.72 |
Zim Laboratories Financials
Income Statement · Consolidated
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Revenue | ₹374.40 | ₹379.03 | ₹367.42 | ₹398.53 |
| Other Income | ₹11.38 | ₹5.78 | ₹5.18 | ₹6.41 |
| Total Revenue | ₹385.78 | ₹384.82 | ₹372.61 | ₹404.94 |
| Total Expenses | ₹377.57 | ₹366.81 | ₹348.97 | ₹369.59 |
| Profit Before Tax | ₹8.21 | ₹18.01 | ₹23.64 | ₹35.36 |
| Tax | ₹2.37 | ₹5.84 | ₹6.40 | ₹10.92 |
| Profit After Tax | ₹5.84 | ₹12.17 | ₹17.25 | ₹24.43 |
| EPS - Basic | ₹1.19 | ₹2.50 | ₹3.54 | ₹5.01 |
| EPS - Diluted | ₹1.19 | ₹2.50 | ₹3.54 | ₹5.01 |
Cash Flow · Consolidated
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Profit before tax | ₹8.21 | ₹18.01 | ₹23.64 | ₹35.36 |
| Income before WC changes | ₹37.31 | ₹51.64 | ₹45.65 | ₹57.51 |
| Change in Assets | -₹7.30 | -₹5.21 | -₹34.69 | ₹24.27 |
| Change in Liabilities | ₹23.26 | -₹6.36 | ₹7.91 | -₹37.11 |
| Change in WC | ₹15.96 | -₹11.57 | -₹26.79 | -₹12.84 |
| Cash flow from Operations | ₹49.53 | ₹41.15 | ₹16.28 | ₹37.52 |
| Cash flow from Investing | -₹56.35 | -₹39.93 | -₹73.01 | -₹36.20 |
| Cash flow from Financing | ₹28.19 | -₹9.10 | ₹59.53 | ₹0.55 |
| Total Cash Flow | ₹23.18 | -₹7.65 | ₹3.18 | ₹3.00 |
| Cash (Start of the year) | ₹1.95 | ₹9.60 | ₹6.42 | ₹3.42 |
| Cash (End of the year) | ₹25.12 | ₹1.95 | ₹9.60 | ₹6.42 |
Balance Sheet · Consolidated
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Non-Current Assets | ₹263.58 | ₹240.97 | ₹219.17 | ₹150.63 |
| Current Assets | ₹275.81 | ₹231.31 | ₹227.65 | ₹190.95 |
| Total Assets | ₹539.39 | ₹472.27 | ₹446.82 | ₹341.58 |
| Current Liabilities | ₹190.39 | ₹166.36 | ₹159.43 | ₹110.79 |
| Net Current Asset | ₹85.42 | ₹64.94 | ₹68.22 | ₹80.16 |
| Non-Current Liabilities | ₹52.84 | ₹53.67 | ₹48.65 | ₹30.45 |
| Equity Capital | ₹296.15 | ₹252.24 | ₹238.75 | ₹200.35 |
| Total Equity & Liabilities | ₹539.39 | ₹472.27 | ₹446.82 | ₹341.58 |
Income Statement · Standalone
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Revenue | ₹370.48 | ₹375.64 | ₹365.47 | ₹396.53 |
| Other Income | ₹11.39 | ₹5.62 | ₹4.69 | ₹6.43 |
| Total Revenue | ₹381.87 | ₹381.26 | ₹370.16 | ₹402.96 |
| Total Expenses | ₹373.47 | ₹363.64 | ₹347.12 | ₹367.04 |
| Profit Before Tax | ₹8.40 | ₹17.61 | ₹23.04 | ₹35.92 |
| Tax | ₹2.44 | ₹5.87 | ₹6.28 | ₹10.91 |
| Profit After Tax | ₹5.97 | ₹11.74 | ₹16.76 | ₹25.01 |
| EPS - Basic | ₹1.22 | ₹2.41 | ₹3.44 | ₹5.13 |
| EPS - Diluted | ₹1.22 | ₹2.41 | ₹3.44 | ₹5.13 |
Cash Flow · Standalone
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Profit before tax | ₹8.40 | ₹17.61 | ₹23.04 | ₹35.92 |
| Income before WC changes | ₹36.10 | ₹50.28 | ₹44.40 | ₹56.73 |
| Change in Assets | ₹4.59 | -₹5.50 | -₹41.53 | ₹22.54 |
| Change in Liabilities | ₹10.56 | ₹4.53 | ₹11.17 | -₹37.06 |
| Change in WC | ₹15.16 | -₹0.97 | -₹30.36 | -₹14.52 |
| Cash flow from Operations | ₹47.66 | ₹50.60 | ₹11.47 | ₹35.23 |
| Cash flow from Investing | -₹57.41 | -₹41.31 | -₹71.94 | -₹35.21 |
| Cash flow from Financing | ₹28.19 | -₹9.10 | ₹59.53 | ₹0.55 |
| Total Cash Flow | ₹18.43 | ₹0.19 | -₹0.94 | ₹0.57 |
| Cash (Start of the year) | ₹0.36 | ₹0.17 | ₹1.11 | ₹0.54 |
| Cash (End of the year) | ₹18.80 | ₹0.36 | ₹0.17 | ₹1.11 |
Balance Sheet · Standalone
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Non-Current Assets | ₹272.77 | ₹248.04 | ₹224.79 | ₹156.23 |
| Current Assets | ₹252.43 | ₹216.35 | ₹217.71 | ₹178.64 |
| Total Assets | ₹525.20 | ₹464.39 | ₹442.50 | ₹334.87 |
| Current Liabilities | ₹186.01 | ₹166.20 | ₹161.90 | ₹110.24 |
| Net Current Asset | ₹66.42 | ₹50.15 | ₹55.82 | ₹68.40 |
| Non-Current Liabilities | ₹52.84 | ₹53.67 | ₹48.65 | ₹30.45 |
| Equity Capital | ₹286.35 | ₹244.51 | ₹231.95 | ₹194.18 |
| Total Equity & Liabilities | ₹525.20 | ₹464.39 | ₹442.50 | ₹334.87 |
About Zim Laboratories
ZIM Laboratories Limited is a pharmaceutical company. The Company develops, manufactures and supplies oral, solid differentiated generic pharmaceutical formulations and pre-formulation intermediaries (PFI) in various therapeutic segments. Its delivery solutions cover product conceptualization product development, filing for registration, manufacture, and supply of various pharmaceutical formulations. It is developing products in various therapeutic segments like, central nervous system, anti-biotic and anti-infective, gastrointestinal, cardiovascular, analgesic/pain management, urology and vitamins, minerals, and dietary supplements. Its technological capabilities include drug release modification, solubility and stability enhancement, taste masking and dosage form transformation. Its product offerings include finished formulations and pre-formulations intermediates, which include granules, pellets, taste-masked powders, dry suspensions, tablets, capsules, and oral thin films.
Zim Laboratories Financial Highlights
- Revenue: Zim Laboratories reported revenue of ₹385.78 crore in FY26 vs ₹384.81 crore in FY25. It showed an increase of 0.25% on a yearly basis.
- Operating Profit: Zim Laboratories reported an operating profit of ₹8.21 crore in FY26 vs ₹18.01 crore in FY25. It showed a decrease of 54.41% on a year-on-year basis.
- Net Profit: Zim Laboratories reported a net profit of ₹5.84 crore in FY26 vs ₹12.17 crore in FY25. It showed a decrease of 52.01% on a yearly basis.
Zim Laboratories Quarterly Result Highlights
- Zim Laboratories reported revenue of ₹111.43 crore in Mar 2026, compared with ₹110.36 crore in Dec 2025, representing an increase of 0.97% on a quarter-on-quarter (QoQ) basis.
- Zim Laboratories reported an operating profit of ₹4.94 crore in Mar 2026, compared with ₹6.05 crore in Dec 2025, representing a decrease of 18.35% on a quarter-on-quarter (QoQ) basis.
- Zim Laboratories reported a profit of ₹3.74 crore in Mar 2026, compared with ₹4.40 crore in Dec 2025, reflecting a decrease of 15.00% on a QoQ basis.
- The earnings per share (EPS) of Zim Laboratories stood at ₹1.19 during Mar 2026.
Similar Stocks
FAQs on Zim Laboratories Share Price
What is Zim Laboratories share price today?
Zim Laboratories share price is ₹122.01 as on 03 Jul, 2026, 15:14 IST.
How has the Zim Laboratories share price performed in the past?
In the last 1 year, Zim Laboratories delivered a return of 13.15%. The Zim Laboratories share price hit a high of ₹133.90 and low of ₹59.31.
How much is the Mutual Fund shareholding in Zim Laboratories shares?
The Mutual Fund Shareholding in Zim Laboratories was 0.00% at the end of Mar 2026.
What is the the 52-week high and low of Zim Laboratories shares ?
The 52-week high and low of Zim Laboratories share is ₹133.90 and ₹59.31 as of 03 Jul, 2026.
What is the market cap of Zim Laboratories?
The market capitalisation of Zim Laboratories is ₹659.19 Crores as on 03 Jul, 2026.
What are the stock symbols of Zim Laboratories?
The stock symbol of Zim Laboratories is ZIMLAB on the NSE, 541400 on the BSE, and the ISIN is INE518E01015.
What was yesterday's closing price of Zim Laboratories shares ?
Zim Laboratories shares closed yesterday at ₹124.50 on NSE & ₹123.10 on BSE
How to buy Zim Laboratories shares?
To buy Zim Laboratories shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
Can I buy Zim Laboratories shares on Holidays?
No, shares of Zim Laboratories or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell Zim Laboratories shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
What is the PE and PB ratio of Zim Laboratories?
The PE and PB ratio of Zim Laboratories is 54.93 and 1.09 respectively, as on 03 Jul, 2026, 15:14 IST.